1-20 of 29
Authors: Christina von Roemeling
Sort by
Journal Article
IMMU-31. DAMAGE RESPONSE FROM SYSTEMIC RNA VACCINATION RESTORES HUMORAL IMMUNITY IN GLIOBLASTOMA
Rachel Moor and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii159, https://doi.org/10.1093/neuonc/noae165.0624
Published: 11 November 2024
Journal Article
EXTH-58. BLOCKING IMMUNE CHECKPOINT— LAIR1: DISRUPTING THE LAIR1—FXIII-A—COLLAGEN IMMUNOSUPPRESSIVE CIRCUIT FOR ENHANCED ANTITUMOR THERAPEUTICS
Haipeng Tao and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii250, https://doi.org/10.1093/neuonc/noae165.0989
Published: 11 November 2024
Journal Article
EXTH-48. ADENO-ASSOCIATED VIRUS TARGETING OF THE TUMOR MICROENVIRONMENT TO IMPROVE LYMPHOCYTE RECRUITMENT IN GLIOBLASTOMA
Christina von Roemeling and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii247–viii248, https://doi.org/10.1093/neuonc/noae165.0979
Published: 11 November 2024
Journal Article
EXTH-76. REDIRECTING STROMAL CELLS TO IGNITE ANTI-TUMOR IMMUNITY AGAINST GLIOBLASTOMA
Anna DeVries and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii254, https://doi.org/10.1093/neuonc/noae165.1006
Published: 11 November 2024
Journal Article
TMIC-52. DECODING METABOLIC INTERACTIONS IN GLIOBLASTOMA TUMOR MICROENVIRONMENT THROUGH COMPREHENSIVE SPATIAL TRANSCRIPTOMIC AND PROTEOMIC ANALYSIS
Avirup Chakraborty and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii310, https://doi.org/10.1093/neuonc/noae165.1230
Published: 11 November 2024
Journal Article
DIPG-18. MULTIMODALITY VISUALIZATION OF A PRECLINICAL MODEL OF DIFFUSE MIDLINE GLIOMA DEMONSTRATES CLEAR TREATMENT EFFECT AFTER RNA NANOPARTICLE THERAPY
Rachel Moor and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.071
Published: 18 June 2024
Journal Article
EXTH-22. AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY
Haipeng Tao and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v228, https://doi.org/10.1093/neuonc/noad179.0875
Published: 10 November 2023
Journal Article
EXTH-07. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR MICROENVIRONMENT POST-SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
Lan Hoang-Minh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v225, https://doi.org/10.1093/neuonc/noad179.0861
Published: 10 November 2023
Journal Article
EXTH-81. RE-EXPRESSION OF CXCL9 FOLLOWING ADENO-ASSOCIATED VIRUS (AAV) TRANSGENE DELIVERY TRANSFORMS THE IMMUNOLOGICAL LANDSCAPE OF GLIOBLASTOMA, SENSITIZING TUMORS TO PD-1 IMMUNE CHECKPOINT BLOCKADE (ICB)
Christina von Roemeling and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v243, https://doi.org/10.1093/neuonc/noad179.0934
Published: 10 November 2023
Journal Article
IMMU-33. PRECISION ANTIGEN-DIRECTED IMMUNOTHERAPY TREATMENT OF BRAIN TUMORS INCREASES TUMOR-INFILTRATING EFFECTOR LYMPHOCYTE RESPONSES
Vrunda Trivedi and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v149, https://doi.org/10.1093/neuonc/noad179.0565
Published: 10 November 2023
Journal Article
CNSC-30. CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE
Anjali Chauhan and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v29, https://doi.org/10.1093/neuonc/noad179.0114
Published: 10 November 2023
Journal Article
IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
James McGuiness and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i50, https://doi.org/10.1093/neuonc/noad073.193
Published: 12 June 2023
Journal Article
Association of circulating markers with cognitive decline after radiation therapy for brain metastasis
Kristin Huntoon and others
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1123–1131, https://doi.org/10.1093/neuonc/noac262
Published: 06 December 2022
Journal Article
EXTH-93. THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA
Christina von Roemeling and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii231, https://doi.org/10.1093/neuonc/noac209.891
Published: 14 November 2022
Journal Article
EXTH-38. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR IMMUNE MICROENVIRONMENT AFTER SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
Lan Hoang-Minh and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii217–vii218, https://doi.org/10.1093/neuonc/noac209.836
Published: 14 November 2022
Journal Article
EXTH-92. TARGETING PRIMARY CENTRAL NERVOUS SYSTEM B CELL LYMPHOMA IGH CLONOTYPES USING NOVEL RNA-NPS
Elizabeth Ogando-Rivas and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii230–vii231, https://doi.org/10.1093/neuonc/noac209.890
Published: 14 November 2022
Journal Article
TMIC-56. TUMOR CELL ARCHITECTURAL HETEROGENEITY AND SPATIAL INTERACTIONS WITH THE TUMOR IMMUNE MICROENVIRONMENT IN GBM
Aryeh Silver and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii283–vii284, https://doi.org/10.1093/neuonc/noac209.1100
Published: 14 November 2022
Journal Article
EXTH-71. CHEMOTACTIC RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV) VIROTHERAPY IMPROVES LYMPHOCYTE RECRUITMENT IN GLIOBLASTOMA (GBM)
Christina von Roemeling and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii225, https://doi.org/10.1093/neuonc/noac209.869
Published: 14 November 2022
Journal Article
EXTH-57. IDENTIFICATION OF NOVEL IMMUNE CHECKPOINT MOLECULE IN GLIOMA, LAIR1
Haipeng Tao and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii222, https://doi.org/10.1093/neuonc/noac209.855
Published: 14 November 2022
Journal Article
CTIM-28. MULTILAMELLAR MRNA LIPID PARTICLES INDUCE IMMUNOLOGIC REPROGRAMMING IN CANINE AND HUMAN GLIOBLASTOMA PATIENTS
Hector Mendez-Gomez and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii66–vii67, https://doi.org/10.1093/neuonc/noac209.260
Published: 14 November 2022
Advertisement
Advertisement